Amarin Corp Plc (AMRN)

[couldbebetter]

massulo52, I still wonder why JT chose HLS for Canada when the company
has no sales force. Maybe he had a valid reason, but I feel uneasy
when I think about it because I think Vascepa needs an experienced
sales force to effectively sell the drug. When one considers the
complexity of drug sales in Europe I hope we do not partner because
then you are at the mercy of your partner for success or failure.
IF JT is looking for the right offer for a buyout, I hope he finds it.
I believe a company such as Roche, which is headquartered in Geneva
would be much more motivated and qualified to optimize Vascepa
revenues if they own AMRN rather than partner for it. HDGabor has
provided much background information on how drug sales work in
Europe. Unless the people involved in the negotiations are seasoned
veterans in the trade I would be reluctant to trust anyone else to
do a deal. If HLS is an example of the best that JT can do for
AMRN in a P&D deal I'd be very afraid if he tries to do the same
for Europe.